Showing 4,941 - 4,960 results of 4,968 for search 'data set detection', query time: 0.21s Refine Results
  1. 4941

    Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial. by Jian Zhang, Yanchun Meng, Biyun Wang, Xinhong Wu, Hongmei Zheng, Jing Hu, Wei Liu, Wenyan Chen, Leiping Wang, Jun Cao, Zhonghua Tao, Ting Li, Sujie Ni, Zhengyan Yu, Lichun Sun, Yun Wang, Qiang Peng, Song Wang, Xin Hu, Jianfei Wang, Yijia Wu, Xichun Hu

    Published 2025-07-01
    “…Of interest, no objective response was observed in three patients with detected BRCA mutations (n = 2) or increased 68Ga-HER2 affibody uptake over the initial two cycles (n = 2). …”
    Get full text
    Article
  2. 4942

    ON DISCRETE STRUCTURE OF GEOLOGIC MEDIUM AND CONTINUAL APPROACH TO MODELING ITS MOVEMENTS by Sh. A. Mukhamediev

    Published 2016-09-01
    “…Authors who support the second opinion, either explicitly or implicitly assume that the block structure of the geologic medium, which is detectable by geological methods, makes a direct and unambiguous impact on all other mechanical properties of the geologic medium and, above all, on the nature of its movements.Based on results obtained by interpreting the data collected in our long-term field studies of rock fracturing, mathematical processing of GPS-measurements, and theoretical models, we agree with the concept of the geologic medium’s block structure, but argue that the geologic block-structure property is not acquired but congenital. …”
    Get full text
    Article
  3. 4943
  4. 4944

    Multi-Target Mechanism of Compound Qingdai Capsule for Treatment of Psoriasis: Multi-Omics Analysis and Experimental Verification by Qiao Y, Li C, Chen C, Wu P, Yang Y, Xie M, Liu N, Gu J

    Published 2025-06-01
    “…The traditional Chinese medicine, Compound Qingdai Capsule (CQC), has shown potential benefits in treating psoriasis in clinical settings. Despite its efficacy, the molecular mechanisms underpinning its therapeutic action remain unclear.Purpose: This study aimed to unravel the molecular mechanism of Compound Qingdai Capsule for psoriasis based on the psoriasis pathogenic pathway network, integrating multi-omics analysis, systems pharmacology, machine learning modeling, and animal experimentation.Methods: Psoriasis pathogenic pathway network was constructed through employing bioinformatics analysis and psoriasis-related multi-omics data mining. …”
    Get full text
    Article
  5. 4945

    The effect of dexmedetomidine on acute kidney injury after elective major abdominal surgery : a retrospective single-center propensity score matched study by Haibei Liu, Rong Luo, Liu Qian, Yujun Zhang, Wensheng Zhang, Juan Tan, Ling Ye

    Published 2024-12-01
    “…However, though additional prospective data are needed, our study found that administering dexmedetomidine with a loading dose may be associated with lower rates of AKI, potentially indicating a renoprotective effect of loading-dose dexmedetomidine in this setting.…”
    Get full text
    Article
  6. 4946

    Supporting antiretroviral therapy uptake and adherence: the SUPA research programme and RCT by Rob Horne, Caroline Sabin, Trudie Chalder, Vanessa Cooper, Lucy Campbell, Elizabeth Glendinning, Iris Mosweu, Paul McCrone

    Published 2025-07-01
    “…Owing to the challenges in using MEMS, the number of participants with sufficient data for primary end-point analysis was 112 (CAU, n = 55; CBT, n = 57). …”
    Get full text
    Article
  7. 4947

    Clinical manifestations and prognosis of giant cell arteritis: A retrospective cohort study by E. E. Filatova, N. M. Bulanov, A. D. Meshkov, O. O. Borodin, I. O. Smitienko, E. V. Chachilo, A. A. Nartov, A. L. Filatova, A. V. Naumov, P. I. Novikov, S. V. Moiseev

    Published 2024-01-01
    “…Clinical, laboratory and instrumental data, three sets of classification criteria were used to confirm the diagnosis: the American College of Rheumatology (ACR) 1990, the revised ACR criteria of 2016 and/or the new ACR and European Alliance of Associations for Rheumatology (EULAR) 2022 criteria. …”
    Get full text
    Article
  8. 4948
  9. 4949

    Biomarkers and outcomes in hospitalised patients with COVID-19: a prospective registry by Rajeev Gupta, Yogendra Singh, Kartik Mittal, Raghubir Singh Khedar, Krishnakumar Sharma, Harshad C Ambaliya, Jugal B Gupta, Surendra Singh, Swati Sharma, Alok Mathur

    Published 2022-12-01
    “…Primary outcome was all-cause deaths and secondary outcome was oxygen requirement, non-invasive and invasive ventilation, dialysis, duration of stay in ICU and hospital. Numerical data are presented in median and interquartile range (IQR 25–75). …”
    Get full text
    Article
  10. 4950

    Understanding the genomic landscape of Klebsiella pneumoniae: insights into bacteraemia across North-West London hospitals between April 2020-December 2021 by Mr Jonah Rodgus, Dr Maria Getino, Dr Yu Wan, Dr Frances Davies, Professor Alison Holmes, Dr Elita Jauneikaite

    Published 2025-03-01
    “…Critically, four distinct carbapenemase genes were identified (n=11), with two OXA-48-like genes (blaOXA-181 [n=2] and blaOXA-48 [n=6]) detected in eight isolates (two from ST15), consistent with national data to suggest a predominance of OXA-48-like genes among carbapenemase genes in England. blaCTX-M-15 (n=92), which confers cefotaxime resistance, was the most common β-lactamase gene, followed by variants of blaTEM-1-D (n=82), which confer resistance to penicillins/first-generation cephalosporins. …”
    Get full text
    Article
  11. 4951
  12. 4952

    Invasive urodynamic investigations in the management of women with refractory overactive bladder symptoms: FUTURE, a superiority RCT and economic evaluation by Mohamed Abdel-Fattah, Christopher Chapple, Suzanne Breeman, David Cooper, Helen Bell-Gorrod, Preksha Kuppanda, Karen Guerrero, Simon Dixon, Nikki Cotterill, Karen Ward, Hashim Hashim, Ash Monga, Karen Brown, Marcus Drake, Andrew Gammie, Alyaa Mostafa, Rebecca Bruce, Victoria Bell, Christine Kennedy, Suzanne Evans, Graeme MacLennan, John Norrie

    Published 2025-07-01
    “…A self-completed 3-day bladder diary was also collected at baseline and 6 and 15 months post-randomisation. Sample size Outcome data were required on 986 participants per group for 90% power to detect a minimum of 10% superiority of urodynamics over CCA only. …”
    Get full text
    Article
  13. 4953
  14. 4954

    Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells by Michele Pezzella, Concetta Quintarelli, Maria C. Quadraccia, Andrea Sarcinelli, Simona Manni, Laura Iaffaldano, Alessio Ottaviani, Roselia Ciccone, Antonio Camera, Maria L. D’Amore, Stefano Di Cecca, Matilde Sinibaldi, Marika Guercio, Mariasole Aurigemma, Pamela De Falco, Valentina Fustaino, Rossella Rota, Silvia Pomella, Matteo Cassandri, Angela Di Giannatale, Chiara Agrati, Veronica Bordoni, Federica Guarracino, Michele Massa, Giada Del Baldo, Marco Becilli, Giuseppe M. Milano, Francesca Del Bufalo, Franco Locatelli, Biagio De Angelis

    Published 2024-12-01
    “…In this preclinical study, we investigated the potential use of iCasp9.2A.GD2.CAR-CD28.4–1BBζ (CAR.GD2) T-cells as a treatment option for patients who have GD2-positive sarcomas and we sought to identify factors shaping hostile tumor microenvironment in this setting. GD2 expression was evaluated by flow-cytometry on primary tumor biopsies of pediatric sarcoma patients. …”
    Get full text
    Article
  15. 4955
  16. 4956
  17. 4957

    Improved Artificial Bee Colony Optimization Underwater Localization Algorithm by Logistic Chaos Mapping and Differential Evolution by Jiaxing CHEN, Yang LIU, Xiaoqian LIU, Zhihua LIU

    Published 2025-01-01
    “…It is relatively straightforward to implement and comprises four phases: population initialization, leading bee, following bee, and detecting bee. The artificial bee colony algorithm offers a novel approach to improving the accuracy of underwater node localization. …”
    Get full text
    Article
  18. 4958

    Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCT by Graham Devereux, Seonaidh Cotton, Mintu Nath, Nicola McMeekin, Karen Campbell, Rekha Chaudhuri, Gourab Choudhury, Anthony De Soyza, Shona Fielding, Simon Gompertz, John Haughney, Amanda Lee, Graeme MacLennan, Alyn Morice, John Norrie, David Price, Philip Short, Jorgen Vestbo, Paul Walker, Jadwiga Wedzicha, Andrew Wilson, Olivia Wu, Brian Lipworth

    Published 2025-05-01
    “…Participants were followed up in the study for 52 weeks, and outcome data were collected at 26 and 52 weeks – prior to the COVID-19 pandemic, these were conducted in a face-to-face setting; while, during and after the COVID-19 pandemic, these were primarily conducted by telephone. …”
    Get full text
    Article
  19. 4959
  20. 4960